KM11060 is a small molecule corrector that addresses the F508del-CFTR trafficking defect, enhancing the delivery and functional expression of the CFTR channel at the cell surface. It is a research tool used in vitro to study cystic fibrosis pathophysiology and the rescue mechanisms of mutant CFTR.